LINC01856

Across TCGA pan-cancer cohorts, LINC01856 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01856 data layer compared with 1 for mutation status.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC01856 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01856 expression acts as an unfavorable survival marker, although some lineages such as BRCA and BLCA show a favorable association.

BRCA, KICH, and UCEC are the cancer types where LINC01856 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Quartile	All	0.989	0.955	<.001	60	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
UCEC	DFS	Quartile	All	0.459	0.705	.010	14	view →
LAML	DFS	Tertile	All	0.389	0.670	.014	12	view →
SKCM	OS	Tertile	All	0.706	0.796	.024	9	view →
BLCA	DFS	Tertile	IV	0.754	0.269	.006	9	view →
LUSC	OS	Tertile	II,III,IV	0.190	0.429	.024	9	view →
SARC	DFS	Tertile	All	0.696	0.564	.013	9	view →
KIRC	DFS	Tertile	All	0.723	0.830	.027	8	view →
GBM	OS	Tertile	All	0.201	0.281	.037	4	view →
ESCA	OS	Quartile	II,III,IV	0.665	0.437	.015	3	view →
STAD	DFS	Median	III,IV	0.421	0.539	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01856–BRCA (OS)

Open the BRCA breakdown →